Why Should You Add ProAssurance (PRA) to Your Portfolio?

Published on November 30, 2021

Riding on inorganic growth and cost-curbing measures, ProAssurance (PRA) holds the potential to reap benefits for investors.

Continue reading on website
Other news

The unbundling of professional learning and entrepreneurship education

November 30, 2021
Rhys Spence Contributor Rhys Spence is head of research at Brighteye Ventures, a European edtech-focused fund, where he works with portfolio companies to help address priorities, with a focus on internationalization and HR. More posts by this contributor What we can learn from edtech startups’ expansion efforts in Europe The 2021 edtech avalanche has

Adagene (ADAG) Gets FDA Nod to Begin Solid Tumor Antibody Study

November 30, 2021
The FDA grants Adagene (ADAG) a clearance to initiate clinical studies of its investigational candidate ADG116 in combination with pembrolizumab to treat advanced/metastatic solid tumors.